ArticleFrontiers in cardiovascular medicine2023

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial.

Teng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.